IPSEN : Innovation for patient care

  • News
  • Our Products
  • Disease Areas

Our Products

Endocrinology


Description

Somatuline LA T is a sustained release formulation of lanreotide. Lanreotide is an octopeptide, an analogue of the natural hormone, somatostatin.

Indications

Acromegaly: Somatuline LA is indicated for the treatment of acromegaly when the circulating levels of growth hormone and insulin-like growth factor remain abnormal after surgery and/or radiotherapy, or in patients who require treatment prior to such intervention.

Thyrotrophic Adenomas: Somatuline LA is indicated for the treatment of primary thyrotrophic adenomas.

Neuroendocrine Tumours: Somatuline LA is also indicated for the relief of symptoms associated with carcinoid tumours.

FULL PRESCRIBING INFORMATION

In compliance with the guidelines of the Irish Pharmaceutical Healthcare Association, the self-regulatory body of the pharmaceutical industry in Ireland, the full prescribing information for all of Ipsen's products in Ireland are available now on www.medicines.ie